Germany's DAX touches fresh record high on ECB rate cut hopes
Reuters
Published Dec 06, 2023 08:28
Updated Dec 06, 2023 17:20
By Khushi Singh, Ankika Biswas and Bansari Mayur Kamdar
(Reuters) -Germany's benchmark index scaled a fresh all-time high on Wednesday after disappointing industrial orders data in the euro zone's largest economy supported bets of a swift run in rate cuts from the European Central Bank next year.
The pan-European STOXX 600 index rose 0.6%, while Germany's DAX closed 0.8% higher.
Data showed a surprising decline in German industrial orders in October, down 3.7% month-on-month, reinforcing expectations of European Central Bank rate cuts next year following a dovish shift from German ECB board member Isabel Schnabel on Tuesday.
Equities were supported by a slide in eurozone government bond yields to multi-month lows.
Bonds found further support after data on U.S. job openings led investors to price in that the Federal Reserve will cut interest rates as soon as March.
"We're basically arguing about when rate cuts might be coming, but they are going to be first in Europe as it was sort of first into the economic downturn," said Ben Laidler, global markets strategist at investing platform eToro.
Basic resources gained 1.6%, tracking a rise in most base metal prices, while stocks in the travel & leisure sector rose 2.3% as TUI (LON:TUIT) jumped 14.8% after Europe's biggest travel operator forecast a sharp jump in operating profit in 2024.
Among individual stocks, Germany's Volkswagen (ETR:VOWG_p) climbed 5.4% after an audit of its jointly owned site in Xinjiang, China, found no signs of forced labour.
Weir Group (LON:WEIR) rose 1.6% as the engineering firm forecast an operating margin of 20% in 2026 and raised its absolute savings target.
Ocado (LON:OCDO) Group added 2.4% after J.P.Morgan upgraded the online supermarket and technology group's stock to "neutral" from "underweight".
Merck tanked 13.1% to the bottom of STOXX 600 after the pharmaceutical company's experimental multiple sclerosis drug - evobrutinib - failed to meet the primary goal in late-stage trials.
British American Tobacco (LON:BATS) lost 8.4% after saying it would take a hit of around $31.5 billion on writing down the value of some U.S. cigarette brands.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.